Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
GALT
#3040
Galectin Therapeutics Inc.
2.9
8
-1.32%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-1.32%
Monthly Change
-5.40%
6 month change
-25.87%
Cambio anual
+104.11%
Cierres anteriores
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
Volumen
21
Markets
Acciones
Atención Sanitaria
GALT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
62.76 M
63.18 M
63.29 M
64.06 M
64.47 M
—
Valuation ratios
Enterprise value
146.04 M
66.88 M
70.28 M
121.89 M
262.01 M
521.06 M
Price to earnings ratio
-3.77
-1.7
-1.69
-3.3
-7.18
-13.87
Price to sales ratio
455.96
136.7
-299.01
183.93
124.5
146.11
Price to cash flow ratio
-5.05
-1.92
-2.04
-3.71
-8.7
-16.37
Price to book ratio
-0.54
-0.76
-0.19
-0.31
-0.58
-1.84
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.39
0.68
1.01
0.48
0.64
2.81
Return on equity %
0.12
0.11
0.08
0.06
0.07
0.33
Return on invested capital %
—
—
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
1 203.98
-1 087.31
31.59 K
421.99
190.39
31.11 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
1 490.04
-1 046.98
38.52 K
686.22
371.16
38.53 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.13
0.49
0.08
1.43
0.09
2.1
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
-0.05
0
0.09
0.15
0.19
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.14
0.21
0.12
0.1
0.05
0.49
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.43
0.24
0.12
0.22
0.18
0.76
Net current asset value per share
0.46
0.28
0.15
0.24
0.2
0.87
Tangible book value per share
1.5
1.67
1.8
1.87
1.94
7.28
Working capital per share
0.05
-0.29
-1.61
0.07
-1.93
-3.75
Book value per share
1.5
1.67
1.8
1.87
1.94
7.28
Noticias
Il direttore di Galectin Therapeutics Marc Rubin si dimette dal consiglio
Galectin Therapeutics director Marc Rubin resigns from board
Il CFO di Galectin Therapeutics vende azioni per 233.000 dollari
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
oracle, micron tech among market cap stock movers on friday
Il titolo Galectin Therapeutics crolla dopo il feedback della FDA sul farmaco
Galectin Therapeutics stock plummets after FDA feedback on drug
La FDA fornisce feedback sul programma di sviluppo di belapectin di Galectin
FDA provides feedback on Galectin’s belapectin development program
Direttore di Galectin Therapeutics vende azioni per 1,05 milioni di dollari
Gli azionisti di Galectin Therapeutics eleggono membri del consiglio e approvano proposte chiave